JP2010540593A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540593A5
JP2010540593A5 JP2010527450A JP2010527450A JP2010540593A5 JP 2010540593 A5 JP2010540593 A5 JP 2010540593A5 JP 2010527450 A JP2010527450 A JP 2010527450A JP 2010527450 A JP2010527450 A JP 2010527450A JP 2010540593 A5 JP2010540593 A5 JP 2010540593A5
Authority
JP
Japan
Prior art keywords
disease
asthma
dermatitis
syndrome
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010527450A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727223B2 (ja
JP2010540593A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/063185 external-priority patent/WO2009043890A1/en
Publication of JP2010540593A publication Critical patent/JP2010540593A/ja
Publication of JP2010540593A5 publication Critical patent/JP2010540593A5/ja
Application granted granted Critical
Publication of JP5727223B2 publication Critical patent/JP5727223B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010527450A 2007-10-04 2008-10-01 オキサジアゾール・ジアリール化合物 Expired - Fee Related JP5727223B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP07117925 2007-10-04
EP07117925.3 2007-10-04
US99813607P 2007-10-09 2007-10-09
US60/998,136 2007-10-09
PCT/EP2008/063185 WO2009043890A1 (en) 2007-10-04 2008-10-01 Oxadiazole diaryl compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014197234A Division JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物

Publications (3)

Publication Number Publication Date
JP2010540593A JP2010540593A (ja) 2010-12-24
JP2010540593A5 true JP2010540593A5 (enExample) 2013-10-24
JP5727223B2 JP5727223B2 (ja) 2015-06-03

Family

ID=38961274

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010527450A Expired - Fee Related JP5727223B2 (ja) 2007-10-04 2008-10-01 オキサジアゾール・ジアリール化合物
JP2014197234A Withdrawn JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物
JP2016100693A Expired - Fee Related JP6224771B2 (ja) 2007-10-04 2016-05-19 オキサジアゾール・ジアリール化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014197234A Withdrawn JP2015025001A (ja) 2007-10-04 2014-09-26 オキサジアゾール・ジアリール化合物
JP2016100693A Expired - Fee Related JP6224771B2 (ja) 2007-10-04 2016-05-19 オキサジアゾール・ジアリール化合物

Country Status (15)

Country Link
US (2) US8404676B2 (enExample)
EP (1) EP2193126B1 (enExample)
JP (3) JP5727223B2 (enExample)
KR (1) KR20100083814A (enExample)
CN (2) CN101815707B (enExample)
AR (1) AR068730A1 (enExample)
AU (1) AU2008306886B2 (enExample)
BR (1) BRPI0817597A2 (enExample)
CA (1) CA2696829C (enExample)
EA (1) EA201070423A1 (enExample)
ES (1) ES2547877T3 (enExample)
IL (1) IL204520A (enExample)
MX (1) MX2010003614A (enExample)
WO (1) WO2009043890A1 (enExample)
ZA (1) ZA201001217B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010521450A (ja) 2007-03-16 2010-06-24 アクテリオン ファーマシューティカルズ リミテッド S1p1/edg1受容体アゴニストとしてのアミノ−ピリジン誘導体
KR20100083814A (ko) * 2007-10-04 2010-07-22 메르크 세로노 에스. 에이. 옥사디아졸 디아릴 화합물
EA201070422A1 (ru) 2007-10-04 2010-12-30 Мерк Сероно С.А. Производные оксадиазола
US8551463B2 (en) 2007-10-22 2013-10-08 Living Proof, Inc. Hair care compositions and methods of treating hair
EP2250165B1 (en) * 2007-12-21 2018-07-25 Merck Serono S.A. Triazole oxadiazoles derivatives
EP2262799B1 (en) * 2008-03-06 2012-07-04 Actelion Pharmaceuticals Ltd. Pyridine compounds
BRPI0910288A2 (pt) 2008-03-07 2019-09-24 Actelion Pharmaceuticals Ltd composto de derivados de aminometil benzeno, composição farmacêutica que compreende esse composto e uso do mesmo.
WO2010085581A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
WO2010085584A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
WO2010085582A1 (en) 2009-01-23 2010-07-29 Bristol-Myers Squibb Company Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
KR101409131B1 (ko) 2009-07-16 2014-06-17 액테리온 파마슈티칼 리미티드 피리딘-4-일 유도체
US8399451B2 (en) 2009-08-07 2013-03-19 Bristol-Myers Squibb Company Heterocyclic compounds
ES2548683T3 (es) 2010-04-23 2015-10-20 Bristol-Myers Squibb Company Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1
US8318783B2 (en) 2010-04-27 2012-11-27 Allergan, Inc. 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
WO2012040532A1 (en) * 2010-09-24 2012-03-29 Bristol-Myers Squibb Company Substituted oxadiazole compounds and their use as s1p1 agonists
SG191742A1 (en) 2011-01-19 2013-08-30 Actelion Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
US9073881B2 (en) * 2011-09-23 2015-07-07 Hoffmann-La Roche Inc. Benzoic acid derivatives
MY192358A (en) 2015-05-20 2022-08-17 Idorsia Pharmaceuticals Ltd Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol
EP4240350A4 (en) * 2020-11-09 2024-09-18 Arena Pharmaceuticals, Inc. <sup2/>? <sub2/>?1?methods of treating conditions related to the s1preceptor
EP4050002A1 (en) * 2021-02-26 2022-08-31 First Health Pharmaceuticals B.V. Anti-proliferative agents

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH623971B5 (de) 1976-06-04 1982-01-15 Hoechst Ag Verfahren zur herstellung neuer benzofuranderivate und deren verwendung als optische aufheller.
US4135910A (en) * 1977-05-12 1979-01-23 Monsanto Company Oxadiazol-3-yl-benzoates as plant growth regulants
DE4320801A1 (de) 1993-06-23 1995-01-05 Fahlberg List Pharma Gmbh 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel
DE19643037A1 (de) * 1996-10-18 1998-04-23 Boehringer Ingelheim Kg Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2887054T3 (es) 2003-04-11 2021-12-21 Ptc Therapeutics Inc Compuesto de ácido 1,2,4-oxadiazol benzoico y su uso para la supresión sin sentido y el tratamiento de enfermedades
CA2524867A1 (en) * 2003-05-15 2004-12-02 Merck & Co., Inc. 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
CN1859908A (zh) * 2003-10-01 2006-11-08 默克公司 作为s1p受体激动剂的3,5-芳基、杂芳基或环烷基取代的-1,2,4-噁二唑类化合物
AU2004299456B2 (en) * 2003-12-17 2010-10-07 Merck Sharp & Dohme Corp. (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
WO2005108370A1 (ja) * 2004-04-16 2005-11-17 Ajinomoto Co., Inc. ベンゼン化合物
JP2008500991A (ja) 2004-05-29 2008-01-17 7ティーエム ファーマ エイ/エス 医学的使用のためのcrth2レセプターリガンド
JP2008517915A (ja) * 2004-10-22 2008-05-29 メルク エンド カムパニー インコーポレーテッド S1p受容体アゴニストとしての2−(アリール)アザシクリルメチルカルボキシレート、スルホネート、ホスホネート、ホスフィネート及びヘテロ環
JP2008545767A (ja) * 2005-06-08 2008-12-18 ノバルティス アクチエンゲゼルシャフト 多環式オキサジアゾールまたはイソキサゾールおよびsip受容体リガンドとしてのそれらの使用
EP1932833B1 (en) 2005-10-07 2012-08-01 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
JP2009269819A (ja) 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
US20100087491A1 (en) 2006-09-29 2010-04-08 Rainer Albert Polycyclic compounds
CN101562977A (zh) 2006-12-15 2009-10-21 艾博特公司 新的二唑化合物
EP2014653A1 (en) 2007-06-15 2009-01-14 Bioprojet Novel dicarboxylic acid derivatives as S1P1 receptor agonists
EA201070422A1 (ru) 2007-10-04 2010-12-30 Мерк Сероно С.А. Производные оксадиазола
KR20100083814A (ko) * 2007-10-04 2010-07-22 메르크 세로노 에스. 에이. 옥사디아졸 디아릴 화합물

Similar Documents

Publication Publication Date Title
JP6506836B2 (ja) B型肝炎ウイルス感染症の処置および予防のための新規ピリダゾンおよびトリアジノン
JP7787063B2 (ja) オーロラキナーゼ阻害剤およびその使用
JP2007515432A5 (enExample)
JP2006528980A5 (enExample)
JP2002528493A5 (enExample)
KR102212975B1 (ko) 피리딘-4-일 유도체
JP2009534407A5 (enExample)
JP2009535307A5 (enExample)
JP2008517915A5 (enExample)
ES2548258T3 (es) Compuestos de oxadiazol sustituidos y su uso como agonistas de S1P1
JP2019533696A (ja) B型肝炎ウイルス感染症の処置及び予防のための新規なテトラヒドロピリドピリミジン
JP2015535832A5 (enExample)
JP2013514980A5 (enExample)
JP2009532417A5 (enExample)
TW200806652A (en) N-hydroxyacrylamide compounds
JP2007522142A5 (enExample)
JP2018509438A5 (enExample)
JP6781848B2 (ja) 新規なピロロピリジン誘導体、その製造方法及び用途
HRP20211121T1 (hr) Supstituirani biciklični spojevi
WO2023169572A1 (zh) 一种三嗪类化合物、其中间体、其制备方法及其用途
JP2007503432A5 (enExample)
JP3539926B2 (ja) 抗ウイルス性ピリミジンジオン誘導体及びそれらの製造方法
EP3239160A1 (en) Tizoxanide phosphate and alkane sulfonate and pharmaceutical applications thereof
JP2006507347A5 (enExample)
CN111606890A (zh) 含丙烯酰基的核转运调节剂及其用途